Specialty Networks and Patient Support Services Summit

Specialty Networks and Patient Support Services Summit is organized by The Healthcare Innovation Company (thINc) and will be held from Oct 29 - 30, 2024 at The Watergate Hotel, Washington, Dist of Col, United States of America.

Description:
The Specialty Networks and Patient Support Services Summit is an important event for senior leaders in patient access, trade, channel, market access, brand and account strategy. Join peers this October to discover the evolving specialty pharmacy marketplace, build multi-stakeholder partnerships, and explore frameworks to enhance your distribution and patient service strategies. Hear directly from specialty pharmacies, payers, PBMs, government agencies, health systems, and industry leaders to:

• Identify actionable strategies to establish an optimal network design and distribution model
• Discover policy and regulatory reform impacting trade and channel distribution
• Explore key considerations for hub and pharmacy alignment to optimize channel strategies and mitigate barriers to patient access
• Gain insight into novel value-based agreements and contracting strategies
• Discuss partnership opportunities in the specialty marketplace to improve patient access
• Uncover the evolving state of cell and gene therapies and biosimilars and what it means for the future
• Create a product specific distribution strategy based on product type, reimbursement and site of care
• Benchmark patient service programs that provide better outcomes, ensure affordability, enhance adherence, and provide patient support.

Topics Covered:

• Value-Driven care powered by data and evidence to enhance patient engagement, improve quality, and minimize spend
• Latest policy developments around the Inflation Reduction Act
• Innovative cross-sector partnerships to expand access and drive affordability while meeting patients where they are
• Creative market access strategies to control costs while ensuring access to complex treatments and therapy
• Spotlight on gene therapy revolution to streamline care for rare disease patients
• Outlook on the role of AI on the pharma industry including causal AI to build accountability and predictability
• Strategies and solutions to address the impact of social determinants of health and other equity-based challenges pertaining to patient access among diverse populations.